Status:
COMPLETED
Real-Life Home Glucose Monitoring Over 14 Days in T2D Patients With Intensified Therapy Using Insulin Pump.
Lead Sponsor:
Air Liquide Santé International
Conditions:
Type 2 Diabetes Mellitus
Eligibility:
All Genders
50+ years
Phase:
NA
Brief Summary
This study aims at describing the glucose level by automated glucose sensors and correlating it with insulin delivery and meals over 14 days in insulin-requiring T2D patients living in real-life condi...
Eligibility Criteria
Inclusion
- Selection criteria:
- Type 2 Diabetes diagnosed for at least 5 years
- Treated with insulin pump for at least 6 months
- 5% ≤ HBA1c ≤ 10% (last available value dated less than 3 months)
- Having given his/her free, express and informed consent to participate to the study
- Inclusion Criteria:
- 5% ≤ HBA1c ≤ 10% (result of the dosage performed at selection visit)
- Daily insulin requirement ≤ 1.5U/kg/day
- Having been compliant to take pictures of his/her meals and snacks over the 3 days prior to the inclusion visit
- Non-selection/Non-inclusion criteria:
- Pregnant or breastfeeding woman
- Comorbidity which, in the investigator's opinion, could jeopardize the study completion
- Patient with difficulties to understand the study procedures or deemed unfit, by the Investigator, to comply with operating instructions of CGM equipment.
Exclusion
Key Trial Info
Start Date :
September 5 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 6 2018
Estimated Enrollment :
24 Patients enrolled
Trial Details
Trial ID
NCT03436212
Start Date
September 5 2017
End Date
March 6 2018
Last Update
September 16 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU de Caen, Service Endocrinologie, Diabétologie
Caen, France, 14033